Literature DB >> 20166949

Enzyme kinetics and hit validation in fluorimetric protease assays.

Stephanie Ludewig1, Markus Kossner, Markus Schiller, Knut Baumann, Tanja Schirmeister.   

Abstract

Fluorimetric assays are convenient and efficient to determine the inhibitory potency of enzyme inhibitors. Since enzyme activity can be blocked in a number of ways, it is important to determine the exact mode of inhibition. The first part of the review deals with kinetic methods to distinguish among the different modes of inhibition. In addition to that, pitfalls are discussed that can be encountered if the mode of inhibition was not thoroughly investigated. The second part of the review deals with some basic techniques of hit validation. Specifically, three error sources that may result in misleadingly strong inhibitors are scrutinized and exemplified for two different typical protease assays (cathepsin B, chymotrypsin). The studied error sources are attenuation of the fluorescence signal, aggregation of the analysed molecules, and irreversible binding of the inhibitor to the enzyme. A simple experimental protocol to detect the aforementioned problems is proposed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20166949     DOI: 10.2174/156802610790725498

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  7 in total

1.  Data quality in drug discovery: the role of analytical performance in ligand binding assays.

Authors:  Hermann Wätzig; Imke Oltmann-Norden; Franziska Steinicke; Hassan A Alhazmi; Markus Nachbar; Deia Abd El-Hady; Hassan M Albishri; Knut Baumann; Thomas Exner; Frank M Böckler; Sami El Deeb
Journal:  J Comput Aided Mol Des       Date:  2015-06-13       Impact factor: 3.686

2.  Dipeptidyl Nitroalkenes as Potent Reversible Inhibitors of Cysteine Proteases Rhodesain and Cruzain.

Authors:  Antonio Latorre; Tanja Schirmeister; Jochen Kesselring; Sascha Jung; Patrick Johé; Ute A Hellmich; Anna Heilos; Bernd Engels; R Luise Krauth-Siegel; Natalie Dirdjaja; Lledó Bou-Iserte; Santiago Rodríguez; Florenci V González
Journal:  ACS Med Chem Lett       Date:  2016-09-21       Impact factor: 4.345

3.  Novel dengue virus NS2B/NS3 protease inhibitors.

Authors:  Hongmei Wu; Stefanie Bock; Mariya Snitko; Thilo Berger; Thomas Weidner; Steven Holloway; Manuel Kanitz; Wibke E Diederich; Holger Steuber; Christof Walter; Daniela Hofmann; Benedikt Weißbrich; Ralf Spannaus; Eliana G Acosta; Ralf Bartenschlager; Bernd Engels; Tanja Schirmeister; Jochen Bodem
Journal:  Antimicrob Agents Chemother       Date:  2014-12-08       Impact factor: 5.191

4.  New tetromycin derivatives with anti-trypanosomal and protease inhibitory activities.

Authors:  Sheila M Pimentel-Elardo; Verena Buback; Tobias A M Gulder; Tim S Bugni; Jason Reppart; Gerhard Bringmann; Chris M Ireland; Tanja Schirmeister; Ute Hentschel
Journal:  Mar Drugs       Date:  2011-09-26       Impact factor: 6.085

5.  Naphthoquinones as Covalent Reversible Inhibitors of Cysteine Proteases-Studies on Inhibition Mechanism and Kinetics.

Authors:  Philipp Klein; Fabian Barthels; Patrick Johe; Annika Wagner; Stefan Tenzer; Ute Distler; Thien Anh Le; Paul Schmid; Volker Engel; Bernd Engels; Ute A Hellmich; Till Opatz; Tanja Schirmeister
Journal:  Molecules       Date:  2020-04-28       Impact factor: 4.411

6.  Anti-protease and immunomodulatory activities of bacteria associated with Caribbean sponges.

Authors:  Paula Tabares; Sheila M Pimentel-Elardo; Tanja Schirmeister; Thomas Hünig; Ute Hentschel
Journal:  Mar Biotechnol (NY)       Date:  2011-01-11       Impact factor: 3.619

7.  Antioxidant and anti-protease activities of diazepinomicin from the sponge-associated Micromonospora strain RV115.

Authors:  Usama Ramadan Abdelmohsen; Matthias Szesny; Eman Maher Othman; Tanja Schirmeister; Stephanie Grond; Helga Stopper; Ute Hentschel
Journal:  Mar Drugs       Date:  2012-10-08       Impact factor: 6.085

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.